Amphetamine and Dextroamphetamine Extended Release Info

Browse eMedTV's wide range of articles related to amphetamine and dextroamphetamine extended release info including topics such as generic for amphetamine-dextroamphetamine extended release, amphetamine-dextroamphetamine extended release dosage, and side effects of amphetamine-dextroamphetamine extended release. Use the search box at the top-right corner of the page to find information about other health topics.

Description of Articles in Amphetamine and Dextroamphetamine Extended Release Info

Amphetamine-dextroamphetamine extended release is a prescription medication that is used to treat ADHD. This eMedTV article offers an overview of this drug, including information on its effects, dosing guidelines, and possible side effects.

This eMedTV segment explains that there are potential side effects of amphetamine-dextroamphetamine extended release, including dizziness, nausea, and insomnia. This page also highlights some of the more serious and rare side effects of this drug.

What is amphetamine-dextroamphetamine extended release used for? This eMedTV resource discusses how amphetamine-dextroamphetamine extended release works to treat ADHD. This page also discusses some off-label uses of the drug.

As this eMedTV page explains, the recommended starting amphetamine-dextroamphetamine extended release dosage varies between 10 mg and 30 mg once daily. Your dosage will be based on several factors, such as your age and any other drugs you're taking.

As this eMedTV Web page explains, potential drug interactions with amphetamine-dextroamphetamine extended release can occur when the drug is taken with Demerol, Urex, or certain antacids, among other medications.

This eMedTV article describes some precautions and warnings with amphetamine-dextroamphetamine extended release, including potential drug interactions and pregnancy risks. This article also discusses who should avoid the drug.

This eMedTV resource explains that a patent prevents any generic for amphetamine-dextroamphetamine extended release from being manufactured. The earliest date that a generic form of the drug could become available is in 2018, when the patent expires.